3Raffetto JD, Khalil RA. Matrix metalloproteinases and their inhibitors in vttseular remodeling anti vascular disease [ J ]. Biochem Pharmacol, 2008, 75 (2) : 346-359.
4Lindeman JH, Abdul-Hussien H, van Bockel JH, et al. Clinical trial of doxycyeline for matrix metalloproteinase-9 inhibition in patients with an abdominal aneurysm: doxyeyeline selectively depletes aortic wall neutrophils and eytotoxic T cells[J]. Circulation, 2009, 119 (16) : 2 209-216.
5Chung AW, Yang HH, Radomski MW, et al. Long-term doxycycline is more effective than atenolol to prevent thoracic aortic aneurysm in maffan syndrome through the inhibition of matrix metalloproteinase-2 and -9 [ J ]. Circ Res, 2008, 102 (8) : e73-85.
6Li YY. Kadokami T, Wang P, et al. MMP inhibition modulates TNF-alpha transgenic mouse phenotype early in the development of heart failure [J]. Am J Physiol Heart Circ Physiol 2002,282 (3) : H983-989.
8Flamant M, Placier S, Dubroca C, et al. Role of matrix metallopvoteinases in early hypertensive vascular remodeling [ J ]. Hypertension, 2007, 50 (1) : 212-218.
9Spiers JP, Kelso 12.1, Siah WF, et al. Alterations in vascular matrix met- alloproteinase due to ageing and chronic hypertension : effects of endothelin receptor blockade [ J ]. J Hypertens, 2005, 23 (9) : 1717-724.
10Marque V, Kieffer P, Atkinson J, et al. Elastic properties and composition of the aortic wall in old spontaneously hypertensive rats [ J ]. Hyperten.ioTa, 1999, 34 (3): 415-422.
